STENOCARE Q2 2025 - opnår break-even
-
Danske Stenocare, som sælger medicinsk cannabisolie, har i dette kvartal nået en milepæl, nemlig break-even. Endda tidligere end forventet. Helge Larsen har Stenocares CEO Thomas Skovlund Schnegelsberg og CFO Peter Bugge Johansen i studiet i forbindelse med selskabets halvårsregnskab - hvor de også kommer ind på det tyske marked, deres patenterede produkt, Astrum, og forventninger til 2026 og 2027.
Disclaimer: Stenocare har betalt IR-samarbejde med Proinvestor.com.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind